APA

Vanmarsenille L., Giannandrea M., Fieremans N., Verbeeck J., Belet S., Raynaud M., Vogels A., Männik K., Õunap K., Jacqueline V., Briault S., Van Esch H., D'Adamo P. & Froyen G. (20141006). Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. : Human mutation.

Chicago

Vanmarsenille Lieselot, Giannandrea Maila, Fieremans Nathalie, Verbeeck Jelle, Belet Stefanie, Raynaud Martine, Vogels Annick, Männik Katrin, Õunap Katrin, Jacqueline Vigneron, Briault Sylvain, Van Esch Hilde, D'Adamo Patrizia and Froyen Guy. 20141006. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. : Human mutation.

Harvard

Vanmarsenille L., Giannandrea M., Fieremans N., Verbeeck J., Belet S., Raynaud M., Vogels A., Männik K., Õunap K., Jacqueline V., Briault S., Van Esch H., D'Adamo P. and Froyen G. (20141006). Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. : Human mutation.

MLA

Vanmarsenille Lieselot, Giannandrea Maila, Fieremans Nathalie, Verbeeck Jelle, Belet Stefanie, Raynaud Martine, Vogels Annick, Männik Katrin, Õunap Katrin, Jacqueline Vigneron, Briault Sylvain, Van Esch Hilde, D'Adamo Patrizia and Froyen Guy. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. : Human mutation. 20141006.